Welcome To ChemAnalyst
The paracetamol industry is seeing moderate price adjustments, supported by firm drug demand in the major markets of China and Germany, which are served by strengthening supply chains and increasing inventories. In China, as a trade leader, paracetamol demand is led by growing over the counter (OTC) pharmaceutical markets and export demand, while in Germany, demand is led by cyclical healthcare and industrial demand. Supply-side considerations such as steady Chinese production and managed German imports are dampening prices within the backdrop of external pressures from energy prices and trade policy. Prices for weekly postings slipped representative of a nervous market sentiment. Paracetamol prices have softened over the last quarter, September levels recording a monthly fall. Next quarter opportunities will be influenced potentially by emerging health trends and geopolitical tensions' attendant risks, with paracetamol's position in international pharmaceutical supply chains brought to the fore.
Key Highlights:
Paracetamol demand remains steady in major end-use markets, particularly pharmaceuticals and consumer healthcare, with strong trends witnessed in China and Germany. Paracetamol demand in China, as a major exporter, is driven by the rapidly expanding OTC medicine market, with retail sales growing xxx annually due to growing awareness of consumer health as well as influenza epidemic outbreaks. Industrial usage...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.